Expanded Potential Stem Cell lines of pig and human cells established
A new approach has enabled researchers to create Expanded Potential Stem Cells (EPSCs) of both pig and human cells. These stem cells have the features of the very first cells in the developing embryo, and can develop into any type of cell. The research from LKS Faculty of Medicine of The University of Hong Kong (HKUMed), the Wellcome Sanger Institute, and the Friedrich-Loeffler-Institut in Germany offers incredible potential for studying human development and regenerative medicine.
The study published in Nature Cell Biology today (3rd June) is the first time scientists have been able to derive stem cells from early pig embryos. Domestic pigs have great potential for biomedical research because of their genetic and anatomical similarities to humans, including comparable organ sizes. Being able to genetically-modify pig stem cells will also be beneficial for animal health and food production.
Stem cells have the ability to develop into other cell types, and existing stem cell lines are already extremely useful for research into development, disease and treatments. However, currently available types of stem cell lines have limitations, and until now it has also not been possible to create embryonic stem cells from pigs and many other farm animals.
“Scientists have been attempting to derive porcine embryonic stem cells for decades without much success. With our Expanded Potential Stem Cell technology, we have now successfully derived and characterised stem cells from porcine preimplantation embryos. We have also established similar human stem cells. Our study represents a significant advance in stem cell research.”
Professor Pentao Liu, the leader of the study from the School of Biomedical Sciences and Stem Cell and Regenerative Medicine Consortium, HKUMed, and previously of the Wellcome Sanger Institute
Since human EPSCs can produce large numbers of placenta cells – called trophoblasts – they offer new opportunities to investigate pregnancy complications such as pre-eclampsia and miscarriages.
EPSCs come from culturing cells from the earliest stage of development, when the fertilised egg has only divided into 4 or 8 cells and the cells retain some totipotency – the ability to produce all cell types.
“These EPSC stem cells possess developmental potency that is not generally seen in conventional embryonic or induced pluripotent stem cells. They have the potential to produce all embryonic and extra-embryonic cell lines – including those in the placenta and yolk sac, turning back the development clock to the very earliest cell type. These cells will enable researchers to study early embryonic development, miscarriage and developmental disorders.”
Dr Xuefui Gao, a first author on the paper from HKUMed, and previously from the Wellcome Sanger Institute
The first EPSCs were created in 2017, when the group targeted key molecular pathways during very early development in mice. At these very earliest embryonic developmental stages, mammalian species are very similar and the cells are like a blank sheet of paper. This study has shown that it is possible to use the same approach to create human EPSCs and also to establish EPSCs from pigs – mammals that had previously been elusive to stem cell researchers.
“Our porcine EPSCs isolated from pig embryos are the first well-characterized pig cell lines worldwide. EPSC’s great potential to develop into any type of cell provides important implications for developmental biology, regenerative medicine, organ transplantation, disease modelling, and screening for drugs.”
Dr Monika Nowak-Imialek, an author on the paper from the Friedrich-Loeffler-Institut (FLI) in Germany
The Latest on: Stem cells
via Google News
The Latest on: Stem cells
- For Research Only - Creative Biolabs' Stem Cell Therapy Development Solutionson November 27, 2020 at 6:09 pm
For over a decade since establishment, Creative Biolabs provides exclusive one-stop services in a systematic manner to global clients to support their RESEARCH on stem cell therapy that has great ...
- Mesenchymal Stem Cells Market Key Growth Factors, development trends, key manufacturers and competitive forecast 2026on November 27, 2020 at 4:26 am
Latest update on Mesenchymal Stem Cells Market Analysis report published with an extensive market research, Mesenchymal Stem Cells market growth analysis and Projection by - 2025. this report is ...
- Inflammation produced by bacterial infection 'alerts' the brain stem cellson November 27, 2020 at 4:24 am
The study, directed by Isabel Fariñas and published in the November digital edition of the journal Cell Stem Cell, reveals that the inflammation produced by a bacterial infection 'alerts' the brain ...
- Embryonic stem cells have their own strategy for protecting chromosome endson November 26, 2020 at 3:00 am
According to new research from CCR scientists, embryonic stem cells have a unique way of protecting their telomeres, the structures at the ends of chromosomes that shorten with every cell division. A ...
- Researchers uncover the unique way stem cells protect their chromosome endson November 25, 2020 at 9:57 am
Telomeres are specialized structures at the end of chromosomes which protect our DNA and ensure healthy division of cells. According to a new study from researchers at the Francis Crick Institute ...
- Mapping out the mystery of blood stem cellson November 25, 2020 at 9:45 am
Princess Margaret scientists have revealed how stem cells are able to generate new blood cells throughout our life by looking at vast, uncharted regions of our genetic material that hold important ...
- New drug lures stem cells to damaged tissue, improves treatment efficacyon November 24, 2020 at 9:30 pm
Scientists at Sanford Burnham Prebys Medical Discovery Institute have created a drug that can lure stem cells to damaged tissue and improve treatment efficacy--a scientific first and major advance for ...
- Regenerative drug summons stem cells for inflammation-free healingon November 24, 2020 at 6:17 pm
Researchers have developed a drug that can mimic inflammation signals to lure stem cells to damaged tissue, without causing any further inflammation. The technique could be a boon for regenerative ...
- Steering Stem Cells to Repair Sites Using Inflammo-Free Inflammo-Attractionon November 24, 2020 at 12:15 pm
Stem cell guidance system delivers balm without the blam, that is, the inflammatory consequences of cytokine-guided migration ...
- Cancer Stem Cells Market Update – Increasing Investment Is Expected To Boost Market Growth in 2027on November 24, 2020 at 1:43 am
Research Dive :The COVID-19 pandemic is expected to impact the global cancer stem cells market in a positive way. Bladder cancer segment will flourish with healthier rate of revenue in the global ...
via Bing News